2015's Top IPOs
- Spark Therapeutics (ONCE) 160.87%
- Global Blood Therapeutics (GBT) 148.65%
- Aclaris Therapeutics, Inc. (ACRS) 112.64%
- Shake Shack (SHAK) 107.05%
- Voyager Therapeutics (VYGR) 94.79%
- Seres Therapeutics, Inc. (MCRB) 93.83%
- Inotek (ITEK) 86.33%
- Aduro Biotech (ADRO) 85.12%
- Penumbra, Inc. (PEN) 69.70%
- Advanced Accelerator Applications (AAAP) 61.25%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Spark Therapeutics (ONCE) to Offer Common Stock
- ZAGG, Inc. (ZAGG) Files $100M Mixed Shelf, 194.3k Common for Shareholders
- The Joint Corp. (JYNT) Completes 2.27M Common Stock Follow-on Offering
- Regency Centers (REG) Settles Common Stock Forward Sale Agreements
- Applied DNA Sciences (APDN) Closes 2.5M Share Registered Direct Offering
- See More
|11/20/2015||Duluth Holdings Inc.||DLTH||6.667 Mil||$12.00||$14.33||19.42%||William Blair, Baird, Raymond James, BMO Capital Markets|
|11/19/2015||Mimecast Limited||MIME||7.75 Mil||$10.00||$10.18||1.80%||Goldman, Sachs & Co.|
|11/19/2015||Axsome Therapeutics||AXSM||5.667 Mil||$9.00||$8.82||-2.00%||Ladenburg Thalmann, Cantor Fitzgerald & Co., Brean Capital|
|11/19/2015||Match Group||MTCH||33.333 Mil||$12.00||$14.41||20.08%||J.P. Morgan, Allen & Company LLC, BofA Merrill Lynch|
|11/19/2015||Square||SQ||N/A||$9.00||$11.90||32.22%||Goldman, Sachs & Co., Morgan Stanley, JP Morgan|
|11/13/2015||Mesoblast Limited||MESO||7.48 Mil||$8.00||$5.57||-30.38%||J.P. Morgan and Credit Suisse|
|11/13/2015||Instructure||INST||4.4 Mil||$16.00||$18.93||18.31%||Morgan Stanley, Goldman Sachs, Jefferies|
|11/13/2015||Xtera Communications||XCOM||5 Mil||$5.00||$5.65||13.00%||Needham & Company, Cowen and Company, BMO Capital|
|11/11/2015||Equity Bancshares||EQBK||1.94 Mil||$22.50||$24.18||7.47%||Keefe, Bruyette & Woods, Inc. and Stephens Inc|
|11/11/2015||Voyager Therapeutics||VYGR||5 Mil||$14.00||$27.27||94.79%||Cowen and Company and Piper Jaffray|
|N/A||Antero Resources Corp.||AR||N/A||N/A||Barclays, Citigroup, J.P. Morgan, Credit Suisse, Jefferies, Wells Fargo Securities|
|N/A||Viking Therapeutics||VKTX||5 Mil||N/A||Oppenheimer & Co. and Roth Capital|
|N/A||Sidoti & Company, Inc.||SDTI||N/A||N/A||WR Hambrecht + Co., Sidoti & Company|
|N/A||Polar Star Realty Trust||PSRT||43.478 Mil||$10-$13||FBR Capital, Wunderlich, ABG Sundal|
|N/A||Sol-Wind Renewable Power, LP||SLWD||8.7 Mil||$19-$21||UBS, Citigroup|
|N/A||Benechill||BNCH||N/A||N/A||Dawson James Securities|
|N/A||Hailiang Education Group||HLG||N/A||N/A||Network 1 Financial Securities|
|N/A||HTG Molecular Diagnostics||HTGM||N/A||N/A||Leerink Partners|
|N/A||Nexvet||NVET||N/A||N/A||BofA Merrill Lynch and Cowen & Company|
|N/A||Sutherland Asset Management||SLD||8.065 Mil||$15-$16||J.P. Morgan, Morgan Stanley, FBR|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.